Abstract
Jun activation domain-binding protein 1 (JAB1) is a multifunctional protein that participates in the control of cell proliferation and the stability of multiple proteins. JAB1 overexpression has been implicated in the pathogenesis of human cancer. JAB1 regulates several key proteins and thereby produces varied effects on cell cycle progression, genome stability and cell survival. However, the biological significance of JAB1 activity in these cellular signaling pathways is unclear. Therefore, we developed mice that were deficient in Jab1 and analyzed the null embryos and heterozygous cells. This disruption of Jab1 in mice resulted in early embryonic lethality due to accelerated apoptosis. Loss of Jab1 expression sensitized both mouse primary embryonic fibroblasts and osteosarcoma cells to γ-radiation-induced apoptosis, with an increase in spontaneous DNA damage and homologous recombination (HR) defects, both of which correlated with reduced levels of the DNA repair protein Rad51 and elevated levels of p53. Furthermore, the accumulated p53 directly binds to Rad51 promoter, inhibits its activity and represents a major mechanism underlying the HR repair defect in Jab1-deficient cells. These results indicate that Jab1 is essential for efficient DNA repair and mechanistically link Jab1 to the maintenance of genome integrity and to cell survival.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adler AS, Lin M, Horlings H, Nuyten DS, van de Vijver MJ, Chang HY . (2006). Genetic regulators of large-scale transcriptional signatures in cancer. Nat Genet 4: 421–430.
Arias-Lopez C, Lazaro-Trueba I, Kerr P, Lord CJ, Dexter T, Iravani M et al. (2006). p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. EMBO Rep 7: 219–224.
Bae MK, Ahn MY, Jeong JW, Bae MH, Lee YM, Bae SK et al. (2002). Jab1 interacts directly with HIF-1alpha and regulates its stability. J Biol Chem 277: 9–12.
Bech-Otschir D, Kraft R, Huang X, Henklein P, Kapelari B, Pollmann C et al. (2001). COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBOJ 20: 1630–1639.
Buscemi G, Perego P, Carenini N, Nakanishi M, Chessa L, Chen J et al. (2004). Activation of ATM and Chk2 kinases in relation to the amount of DNA strand breaks. Oncogene 23: 7691–7700.
Claret FX, Hibi M, Dhut S, Toda T, Karin M . (1996). A new group of conserved coactivators that increase the specificity of AP-1 transcription factors. Nature 383: 453–457.
Collis SJ, Tighe A, Scott SD, Roberts SA, Hendry JH, Margison GP . (2001). Ribozyme minigene-mediated RAD51 down-regulation increases radiosensitivity of human prostate cancer cells. Nucleic Acids Res 29: 1534–1538.
Dong Y, Sui L, Watanabe Y, Yamaguchi F, Hatano N, Tokuda M . (2005). Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas. Clin Cancer Res 11: 259–266.
Doronkin S, Djagaeva I, Beckendorf SK . (2002). CSN5/Jab1 mutations affect axis formation in the Drosophila oocyte by activating a meiotic checkpoint. Development 129: 5053–5064.
Gavrieli Y, Sherman Y, Ben-Sasson SA . (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493–501.
Gupta RC, Bazemore LR, Golub EI, Radding CM . (1997). Activities of human recombination protein Rad51. Proc Natl Acad Sci USA 94: 463–468.
Haaf T, Golub EI, Reddy G, Radding CM, Ward DC . (1995). Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc Natl Acad Sci USA 92: 2298–2302.
Hannay JA, Liu J, Zhu QS, Bolshakov SV, Li L, Pisters PW et al. (2007). Rad51 overexpression contributes to chemoresistance in human soft tissue sarcoma cells: a role for p53/activator protein 2 transcriptional regulation. Mol Cancer Ther 6: 1650–1660.
Harada K, Kawashima Y, Yoshida H, Sato M . (2006). High expression of Jun activation domain-binding protein 1 (Jab1) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation. Anticancer Res 26: 1615–1619.
Harari-Steinberg O, Cantera R, Denti S, Bianchi E, Oron E, Segal D et al. (2007). COP9 signalosome subunit 5 (CSN5/Jab1) regulates the development of the Drosophila immune system: effects on Cactus, Dorsal and hematopoiesis. Genes Cells 12: 183–195.
Jackson SP, Bartek J . (2009). The DNA-damage response in human biology and disease. Nature 461: 1071–1078.
Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW, Vogelstein B . (1992). Oncogenic forms of p53 inhibit p53-regulated gene expression. Science (New York, NY) 256: 827–830.
Khanna KK, Jackson SP . (2001). DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27: 247–254.
Kouvaraki MA, Tian L, Mansouri A, Zhang Q, Kumar R, Kittas C et al. (2003). Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Cancer Res 63: 2977–2981.
Kouvaraki MA, Rassidakis GZ, Korapati A, Tian L, Chiao P, Ho L et al. (2006). Potential role of JAB1 as a negative regulator of p27Kip1 in pancreatic adenocarcinoma. Cancer Res 66: 6589–6597.
Kwok SF, Solano R, Tsuge T, Chamovitz DA, Ecker JR, Matsui M et al. (1998). Arabidopsis homologs of a c-Jun coactivator are present both in monomeric form and in the COP9 complex, and their abundance is differentially affected by the pleiotropic cop/det/fus mutations. Plant Cell 10: 1779–1790.
Lindahl T . (1993). Instability and decay of the primary structure of DNA. Nature 362: 709–715.
Lykke-Andersen K, Schaefer L, Menon S, Deng XW, Miller JB, Wei N . (2003). Disruption of the COP9 signalosome Csn2 subunit in mice causes deficient cell proliferation, accumulation of p53 and cyclin E, and early embryonic death. Mol Cell Biol 23: 6790–6797.
Maacke H, Jost K, Opitz S, Miska S, Yuan Y, Hasselbach L et al. (2000). DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma. Oncogene 19: 2791–2795.
Mundt KE, Porte J, Murray JM, Brikos C, Christensen PU, Caspari T et al. (1999). The COP9/signalosome complex is conserved in fission yeast and has a role in S phase. Curr Biol 9: 1427–1430.
Oh W, Lee EW, Sung YH, Yang MR, Ghim J, Lee HW et al. (2006). Jab1 induces the cytoplasmic localization and degradation of p53 in coordination with Hdm2. J Biol Chem 281: 17457–17465.
Oron E, Tuller T, Li L, Rozovsky N, Yekutieli D, Rencus-Lazar S et al. (2007). Genomic analysis of COP9 signalosome function in Drosophila melanogaster reveals a role in temporal regulation of gene expression. Mol Syst Biol 3: 108.
Peng G, Yim EK, Dai H, Jackson AP, Burgt I, Pan MR et al. (2009). BRIT1/MCPH1 links chromatin remodelling to DNA damage response. Nat Cell Biol 11: 865–872.
Pierce AJ, Jasin M . (2005). Measuring recombination proficiency in mouse embryonic stem cells. Methods Mol Biol 291: 373–384.
Raderschall E, Stout K, Freier S, Suckow V, Schweiger S, Haaf T . (2002). Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res 62: 219–225.
Rassidakis GZ, Claret FX, Lai R, Zhang Q, Sarris AH, McDonnell TJ et al. (2003). Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in sysemic anaplastic large cell lymphoma. Clin Cancer Res 9: 1121–1128.
Russell JS, Brady K, Burgan WE, Cerra MA, Oswald KA, Camphausen K et al. (2003). Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res 63: 7377–7383.
Shinohara A, Ogawa H, Ogawa T . (1992). Rad51 protein involved in repair and recombination in Scerevisiae is a RecA-like protein. Cell 69: 457–470.
Sonoda E, Sasaki MS, Buerstedde JM, Bezzubova O, Shinohara A, Ogawa H et al. (1998). Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBOJ 17: 598–608.
Suh GS, Poeck B, Chouard T, Oron E, Segal D, Chamovitz DA et al. (2002). Drosophila JAB1/CSN5 acts in photoreceptor cells to induce glial cells. Neuron 33: 35–46.
Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y et al. (2001). Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Clin Cancer Res 7: 4130–4135.
Tomoda K, Kubota Y, Kato J . (1999). Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398: 160–165.
Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S, Kato JY . (2004). Multiple functions of Jab1 are required for early embryonic development and growth potential in mice. J Biol Chem 279: 43013–43018.
Tsuzuki T, Fujii Y, Sakumi K, Tominaga Y, Nakao K, Sekiguchi M et al. (1996). Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci USA 93: 6236–6240.
van Gent DC, Hoeijmakers JH, Kanaar R . (2001). Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2: 196–206.
Vispe S, Cazaux C, Lesca C, Defais M . (1998). Overexpression of Rad51 protein stimulates homologous recombination and increases resistance of mammalian cells to ionizing radiation. Nucleic Acids Res 26: 2859–2864.
Walker JR, Corpina RA, Goldberg J . (2001). Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 412: 607–614.
Wan M, Cao X, Wu Y, Bai S, Wu L, Shi X et al. (2002). Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation. EMBO Rep 3: 171–176.
Wei N, Deng XW . (2003). The COP9 signalosome. Annu Rev Cell Dev Biol 19: 261–286.
Xia SJ, Shammas MA, Shmookler Reis RJ . (1997). Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase. Mol Cell Biol 17: 7151–7158.
Yan J, Walz K, Nakamura H, Carattini-Rivera S, Zhao Q, Vogel H et al. (2003). COP9 signalosome subunit 3 is essential for maintenance of cell proliferation in the mouse embryonic epiblast. Mol Cell Biol 23: 6798–6808.
Zhang Q, Tian L, Mansouri A, Korapati AL, Johnson TJ, Claret FX . (2005). Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells. FEBS Lett 579: 3932–3940.
Acknowledgements
We thank Jeffrey Medeiros's laboratory for providing technical help, Dina Lev and Zhi-Xiang Xu for kindly providing the pRad51-luciferase reporter, Rad51 and p53 constructs and Dr Bert Vogelstein for sharing PG13-luc and MG15-Luc plasmids. We also thank Christine Wogan for assistance with the manuscript preparation. This research was supported by the National Institutes of Health Grant RO1 CA90853, the Susan G Komen for the Cure and the NIH Core Grant CA16672.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Tian, L., Peng, G., Parant, J. et al. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair. Oncogene 29, 6125–6137 (2010). https://doi.org/10.1038/onc.2010.345
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.345
Keywords
This article is cited by
-
Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders
Molecular Medicine (2023)
-
Hydroxychloroquine synergizes with the PI3K inhibitor BKM120 to exhibit antitumor efficacy independent of autophagy
Journal of Experimental & Clinical Cancer Research (2021)
-
The proteome, not the transcriptome, predicts that oocyte superovulation affects embryonic phenotypes in mice
Scientific Reports (2021)
-
Genetic controls of Tas1r3-independent sucrose consumption in mice
Mammalian Genome (2021)
-
The crucial p53-dependent oncogenic role of JAB1 in osteosarcoma in vivo
Oncogene (2020)